19.5 5.8 15.7 18.8 14.1 19.5 29.9 5.8 12.0 17.5 13.7 9.5 13.2 16.6 11.1 13.1 22.0 13.2 6 (X) 15.6 10.9 15.0 18.7 14.7 16.9 19.3 6.9 7.7 12.1 13.1 9.3 9.3 10.9 6.8 9.2 16.8 9.7 7 (X) 11.5 13.4 12.1 14.8 13.1 14.2 15.5 6.6 5.7 8.9 9.6 7.0 6.6 8. of short phosphopeptides to recombinant SH2 domains pTyr where Met was highly preferred ( Figure 2C , cycle 7). There was a slight preference for large hydrophobic amino and present a technique that selects the optimal phosphopeptides from a degenerate mixture. The likely sites of acids at the first residue after pTyr (Figure 2A ), but the selectivity at this residue was not nearly as great as that contact between the phosphopeptides and SH2 domains are discussed based on the crystallographic structure prewhen using the N-terminal SH2 domain. Thus, the C-terminal SH2 domain of p85 will bind to the same set of viously determined for two Src SH2-phosphopeptide complexes (Waksman et al., 1992) .
peptides as the N-terminal SH2 domain, but is more promiscuous at the first residue after pTyr and more selective for Met at the third residue. Results
Identification of Phosphopeptide Motifs pTyr-Glu-Glu-Ile Recognition Motif for SH2 Recognized by p85 SH2 Domains
Domains of the Src Family A synthetic phosphopeptide library (Table 1) 
was con-
The same phosphopeptide library was used to determine structed to explore the optimal sequence for binding to optimal sequences for binding to 11 additional SH2 dovarious SH2 domains (see Experimental Procedures). Remains. The results are summarized in Table 3 . The amino combinant SH2 domains were used to affinity purify a subacids that are preferentially selected at the positions ϩ1, group of phosphopeptides from the library. The mixture ϩ2, and ϩ3 C-terminal to the pTyr are presented. The numwas sequenced and the relative abundance of the 18 bers in parentheses indicate the relative preference. The amino acids present at each of the degenerate positions SH2 domains of the Src family members (Src, Fyn, Lck, (cycles 5, 6, and 7) was determined and compared with and Fgr) all selected phosphopeptides with Glu at the ϩ1 the abundance in a control experiment. The results oband ϩ2 positions and Ile at the ϩ3 position C-terminal tained for the N-terminal SH2 domain of the 85 kd subunit of pTyr. of phosphatidylinositol 3-kinase are presented in Figure 1 . This SH2 domain selectively bound phosphopeptides that A pTyr-Glu-Glu-Ile-Containing Peptide Binds to the Src SH2 Domain with High Affinity have Met, Val, Ile, or Glu at residue 5 (first residue after pTyr; Figure 1A ) and Met at residue 7 (third residue after A search of the SwissProtein and GenBank data bases for similar sequences revealed some interesting possible pTyr; Figure 1C ). Data were normalized so a ratio of 1 denotes no amino acid selectivity (which was observed binding sites for the Src family SH2 domains (Table 2) . Of particular interest is a domain in hamster polyoma middle with a denatured SH2 domain; data not shown).
Interestingly, the optimal sequences predicted from this T that includes the predicted optimal sequence for binding to the Src SH2 domain: Glu-Pro-Gln-Tyr-Glu-Glu-Ile-Pro. analysis (pTyr-Met-X-Met or pTyr-Val-X-Met) are precisely the sequences that have been identified as the p85-bindThis protein is known to bind and activate Src family members in vivo (Courtneidge et al., 1991) . Also included in ing sites on polyoma middle T, PDGF receptor, colonystimulating factor 1 receptor, and c-kit. Similar sequences (Table 2) . Some additional proteins with this motif are also presented. since peptides with Pro at 2 residues after pTyr are poorly selected and those with Gln and Gly at positions 1 and 3, The C-terminal SH2 domain of p85 selected a set of phosphopeptides similar to those retained by the N-terrespectively, are intermediate in rank of selection (Table  3 and data not shown). Interestingly, the hamster middle minal SH2 domain ( Figure 2 ). As with the N-terminal SH2 domain the greatest selectivity was at the third cycle after T peptide has similarity to the C-terminal domain (Tyr   527   ) of pp60 c-src N-terminal to pTyr (Glu-Pro-Gln; Table 2 ). While the association of Src family members with mouse polyoma middle T (and probably also hamster middle T) occurs primarily through the N-terminal region of the middle T protein and the C-terminal domain of pp60 c-src (Cheng et al., 1988 ; Piwnica-Worms et al., 1990), a second contact may be made between the identified Tyr 324 of hamster middle T and the SH2 domain of a Src family member. Thus, this domain of hamster middle T might be involved in regulation of tyrosine kinase activity.
Thehamsterpolyoma middleT phosphopeptide(Glu-ProGln-pTyr-Glu-Glu-Ile-Pro-Ile) was synthesized and compared with the phosphopeptide based on the C-terminus of pp60 c-src for the ability to bind to the Src SH2 domain. Relative affinities were compared by competing for the ability of the glutathione S-transferase (GST)-Src SH2 beads to precipitate the PDGF receptor from PDGFstimulated fibroblasts (Figure 3) (Anderson et al., 1990 ). While 50 M Src C-terminal phosphopeptide only blocked about 50% of binding, 0.5 M hamster middle T phosphopeptide blocked more than 90% of binding (the K D for the hamster middle T phosphopeptide was estimated to be 4 nM by direct binding using the BIAcore technique; S. E. S., unpublished data). A phosphopeptide containing the sequence pTyr-Met-Pro-Met also bound more weakly than the hamster middle T phosphopeptide. Adding a methyl group to the phosphate of the hamster middle T phosphopeptide significantly reduced the affinity. Thus, the sequence predicted to be optimal for binding to the Src SH2 domain by the experiment in Figure 3 has a much higher affinity for this domain than does the phosphopeptide based on the C-terminus of pp60 c-src . One might expect the phosphopeptide sequence at the C-terminus of pp60 c-src to have lower affinity than other target sequences if these targets are to compete for the Src SH2 domain in vivo. We have recently shown that a relatively low concentration of the pTyr-Glu-Glu-Ile-containing peptide can activate pp60 c-src in vitro, presumably by displacing the endogenous pTyr 527 moiety .
Motifs for Other SH2 Domains
Unique peptide sequences were selected by each SH2 domain outside the Src family. However, subgroups of SH2 domains that selected similar motifs were observed. The results are presented in domains selected different and unique motifs. The structural basis for the selections will be discussed below. We will also discuss how knowledge of these motifs can be used to predict binding sites for SH2 domains on receptors and other signaling proteins.
The Structural Basis for SH2 Domain Selectivity
The crystal structures of two Src SH2 domain-phosphopeptide complexes provide a basis for predicting contacts between SH2 domains and the side chains of associated phosphopeptides (Waksman et al., 1992) . The two phosphopeptides used in the crystallization (pTyr-Val-Pro-Met and pTyr-Leu-Arg-Val) had relatively low affinities for the Src SH2 domain (consistent with the results in Table 3) , and most of the contacts were made with the pTyr moiety. However, despite distinct sequences for the 3 residues C-terminal to the pTyr and lack of significant contacts with the side chains of the other residues, the backbones of the two peptides associated with the SH2 domain in a similar orientation. Appropriate side chains at the 3 residues C-terminal to the pTyr would be expected to form additional interactions to stabilize the complex further and ex- Table 4 ).
The members of group 1 that have been investigated The major value of the data in Table 3 is that it considerably reduces the work required to determine the in vivo signalselect phosphopeptides with the general motif pTyrhydrophilic-hydrophilic-Ile/Pro. All members with Tyr at ing complexes formed by proteins with SH2 domains. A search of protein sequence data bases for proteins con-␤D5 (Src, Lck, Fyn, Fgr, Abl, Crk, and Nck) select Glu or Asp at the ϩ1 position. The Src family (Src, Lck, Fyn, Fgr, taining the motifs recognized by the various SH2 domains reveals possible sites in proteins that have been previously Yes, Lyn, and Hck) makes up a subgroup of group 1, in which most of the residues that are predicted to contact sequenced. These predictions can then be tested by checking for coimmunoprecipitation of the proteins from all three side chains of the associated phosphopeptide are conserved (top of Table 4 ). Consistent with the conserved lysates of stimulated cells and finally by making point mutations at the predicted binding sites. structure, the SH2 domains from this family that have been investigated all select pTyr-Glu-Glu-Ile as the opti- Table 2 presents some possible binding sites for the SH2 domains whose binding motifs we determined. Some mal peptide.
Crk, Nck, Abl, and Sem5/GRB2 make up another subof these sites have already been shown to bind the predicted SH2 domains (see p85 and PLC-␥). Other sites are group of group 1. All four have an aromatic residue at ␤D5, but the other residues expected to contact the side chains on proteins that are known to bind the respective SH2 domains, but the binding sites have not yet been mapped of the associated peptide are distinct from the analogous sites of the Src family members. The residues predicted (see Src family, Sem5/GRB2, p85, and PLC-␥). The predicted Sem5/GRB2-binding site on SHC was recently conto form the ϩ3 pocket are similar between Crk and Nck and both SH2 domains strongly select Pro at ϩ3. The ϩ3 firmed by point mutation (Pawson laboratory, unpublished data). Other predicted sites for the various SH2 domains pocket of Abl is similar to that of the Src family but has Val rather than Ile at ␤E4. It also shows a preference for Pro are currently being investigated. The successes we have had in predicting the binding sites for p85 (Table 2 ; Cantley over Ile at ϩ3. Sem5/GRB2 is unusual in that it has very weak selectivity et al., 1991) encourage us to pursue the predictions made in Table 2 . Some of these predictions warrant discussion. at the ϩ3 position and selects primarily on the basis of Asn at ϩ2 (Table 3) 
Experimental Procedures
The sequences in Table 2 is found on ErbB3 and on human papilloma virus E5b ( (Table 3 ) and several thousand-fold higher binding sites of phosphatidylinositol 3-kinase, there is a tendency tothan the lowest affinity peptides (data not shown). The ward residues that form bends, and Ser-Pro is likely to form a bend.
optimal affinities were 1 to 50 nM for those SH2 domains
All peptides of the library terminate with three Leu residues to prevent examined. Most SH2 domains examined selected unique wash-out during sequencing.
optimal peptides, and these selections are consistent with
Phosphopeptide Library Synthesis the variability in residues at the contact points (Table 4) . Table 1 . The variability in molar amounts of the individual amino acids found at the ϩ2 and ϩ3 positions C-terminal to pTyr were very similar to those found for the same residues in the more degenerate peptide at a given cycle was generally less than 3-fold as judged by sequencing (some variability is due to recovery in the sequencer) and less than (data not shown), indicating that the selectivity found with the highly degenerate peptide is reliable for this SH2 domain. 2-fold on the basis of amino acid analysis of the mixture. There was some decrease in yield with successive cycles, but since all peptides had the same C-terminal sequence, the wash-out was similar for all
In Vitro Competition peptides.
Quiescent 3T3 cells were stimulated with PDGF ␤ at 37ЊC for 5 min. After washing twice with phosphate-buffered saline, cells were lysed in lysis buffer (20 mM Tris [pH 8.0], 150 mM NaCl, 10% glycerol, 2 mM Affinity Purification EDTA, 1 mM phenylmethylsulfonyl fluoride, 0.15 U/ml aprotinin, 20 A total of 150 l of fusion protein beads (600 g of protein) was packed M leupeptin, 2 mM sodium vanadate, 1% NP-40). Cell lysates were in a 1 ml syringe as an affinity column. The beads were washed with cleared by centrifugation. The supernatants were aliquoted and prein-1 ml of phosphate-buffered saline (150 mM NaCl, 3 mM KCl, 10 mM cubated with different concentrations of phosphorylated peptides at Na2HPO4, 2 mM KH2PO4 [pH 7.2]). Degenerate peptide (2 mg) was 4ЊC for 30 min. GST-Src SH2 fusion protein beads or GST beads were loaded on the top of the column and allowed to sit at room temperature added to a final concentration of 500 nM, and the mixture was shaken for 5 to 10 min. During this period, the column flow was stopped. The at 4ЊC for 90 min. After centrifugation, precipitates were washed three column was then quickly washed twice with 1 ml of ice-cold phosphatetimes in lysis buffer. Proteins on the beads were resolved on SDSbuffered saline (containing 10 mg/ml blue dextran and 0.5% NP-40) polyacrylamide (10%) gel and transferred to the nitrocellulose memand once with 1 ml of ice-cold phosphate-buffered saline at 4ЊC. Presbrane. The proteins on the membrane were probed with anti-phossure was added to accelerate the wash so that the entire washing time phorylated tyrosine antibody (monoclonal 4G10 from UBI). The bands was less than 1 min to avoid peptide dissociation. To elute the peptides, were visualized through enhanced chemiluminescence (Amersham). 200 ml of 20 mM sodium phenylphosphate solution (pH 7.8) was loaded on the column at room temperature. The flowthrough was collected, Acknowledgments dried down into a small volume, and sequenced on the Applied Biosystems 477A Protein Sequencer. Preliminary results using a radiolaThe original modeling of the pTyr-Glu-Glu-Ile phosphopeptide in the beled phosphopeptide ( 125 I-labeled RENEY*MPMAPQIH, based on a Src SH2 domain was done by John Kuriyan (Rockefeller University). sequence in hamster middle T; Y* indicates pTyr) known to bind tightly We thank Dr. Kuriyan for sharing his crystal coordinates and for many to this SH2 domain (KD ϭ 1 nM) confirmed that high affinity peptides informative discussions about modeling, We also thank Stephen Harare retained through the washing procedure and are quantitatively rison (Harvard University) for discussion about the Lck SH2 domain. eluted by phenylphosphate (data not shown). As a control the same We thank Michael Berne (Tufts University School of Medicine, Boston, procedure was performed with GST lacking the SH2 domain. To cor-MA) for microsequencing and for synthesizing some of the phosphorect for the differential recoveries during sequencing, variable abunpeptides. We thank Bill Bachovchin and David Sanford (Tufts Univerdance of amino acids in the degenerate mixture, and potential differsity School of Medicine) for nuclear magnetic resonance analysis to ences in nonspecific adsorption to the control beads, the ratio of each confirm the pTyr and O-methoxyphosphotyrosine content of the phosamino acid in a given cycle of the phosphopeptide mixture retained phopeptides and for modeling of the p85 N-terminal SH2 domain. This on the N-terminal SH2 domain beads to the same amino acid in the work was supported by grants from the National Institutes of Health same cycle of the peptide mixture from the control experiment is plotted and funds from the BASF corporation. (Figure 1 ).
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